Marksans Pharma Ltd
NSE:MARKSANS

Watchlist Manager
Marksans Pharma Ltd Logo
Marksans Pharma Ltd
NSE:MARKSANS
Watchlist
Price: 293.7 INR -0.02% Market Closed
Market Cap: 133.1B INR
Have any thoughts about
Marksans Pharma Ltd?
Write Note

Intrinsic Value

The intrinsic value of one MARKSANS stock under the Base Case scenario is 185.95 INR. Compared to the current market price of 293.7 INR, Marksans Pharma Ltd is Overvalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MARKSANS Intrinsic Value
185.95 INR
Overvaluation 37%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Marksans Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for MARKSANS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about MARKSANS?
Bearish
Neutral
Bullish

Fundamental Analysis

293.7 INR
-0.02%
-0.02%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Marksans Pharma Ltd
IN
Pharmaceuticals
Market Cap
133.1B INR
IPO
Apr 3, 2002
Employees
1 138
India
Market Cap
133.1B INR
Industry
Pharmaceuticals
IPO
Apr 3, 2002
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Marksans Pharma Ltd

Provide an overview of the primary business activities
of Marksans Pharma Ltd.

What unique competitive advantages
does Marksans Pharma Ltd hold over its rivals?

What risks and challenges
does Marksans Pharma Ltd face in the near future?

Has there been any significant insider trading activity
in Marksans Pharma Ltd recently?

Summarize the latest earnings call
of Marksans Pharma Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Marksans Pharma Ltd.

Provide P/S
for Marksans Pharma Ltd.

Provide P/E
for Marksans Pharma Ltd.

Provide P/OCF
for Marksans Pharma Ltd.

Provide P/FCFE
for Marksans Pharma Ltd.

Provide P/B
for Marksans Pharma Ltd.

Provide EV/S
for Marksans Pharma Ltd.

Provide EV/GP
for Marksans Pharma Ltd.

Provide EV/EBITDA
for Marksans Pharma Ltd.

Provide EV/EBIT
for Marksans Pharma Ltd.

Provide EV/OCF
for Marksans Pharma Ltd.

Provide EV/FCFF
for Marksans Pharma Ltd.

Provide EV/IC
for Marksans Pharma Ltd.

Show me price targets
for Marksans Pharma Ltd made by professional analysts.

What are the Revenue projections
for Marksans Pharma Ltd?

How accurate were the past Revenue estimates
for Marksans Pharma Ltd?

What are the Net Income projections
for Marksans Pharma Ltd?

How accurate were the past Net Income estimates
for Marksans Pharma Ltd?

What are the EPS projections
for Marksans Pharma Ltd?

How accurate were the past EPS estimates
for Marksans Pharma Ltd?

What are the EBIT projections
for Marksans Pharma Ltd?

How accurate were the past EBIT estimates
for Marksans Pharma Ltd?

Compare the revenue forecasts
for Marksans Pharma Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Marksans Pharma Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Marksans Pharma Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Marksans Pharma Ltd compared to its peers.

Compare the P/E ratios
of Marksans Pharma Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Marksans Pharma Ltd with its peers.

Analyze the financial leverage
of Marksans Pharma Ltd compared to its main competitors.

Show all profitability ratios
for Marksans Pharma Ltd.

Provide ROE
for Marksans Pharma Ltd.

Provide ROA
for Marksans Pharma Ltd.

Provide ROIC
for Marksans Pharma Ltd.

Provide ROCE
for Marksans Pharma Ltd.

Provide Gross Margin
for Marksans Pharma Ltd.

Provide Operating Margin
for Marksans Pharma Ltd.

Provide Net Margin
for Marksans Pharma Ltd.

Provide FCF Margin
for Marksans Pharma Ltd.

Show all solvency ratios
for Marksans Pharma Ltd.

Provide D/E Ratio
for Marksans Pharma Ltd.

Provide D/A Ratio
for Marksans Pharma Ltd.

Provide Interest Coverage Ratio
for Marksans Pharma Ltd.

Provide Altman Z-Score Ratio
for Marksans Pharma Ltd.

Provide Quick Ratio
for Marksans Pharma Ltd.

Provide Current Ratio
for Marksans Pharma Ltd.

Provide Cash Ratio
for Marksans Pharma Ltd.

What is the historical Revenue growth
over the last 5 years for Marksans Pharma Ltd?

What is the historical Net Income growth
over the last 5 years for Marksans Pharma Ltd?

What is the current Free Cash Flow
of Marksans Pharma Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Marksans Pharma Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Marksans Pharma Ltd

Current Assets 20.8B
Cash & Short-Term Investments 6.8B
Receivables 5.7B
Other Current Assets 8.3B
Non-Current Assets 8.3B
PP&E 6.9B
Intangibles 1.1B
Other Non-Current Assets 344m
Current Liabilities 4.4B
Accounts Payable 2.8B
Short-Term Debt 240.4m
Other Current Liabilities 1.4B
Non-Current Liabilities 1.9B
Long-Term Debt 1.6B
Other Non-Current Liabilities 306.4m
Efficiency

Earnings Waterfall
Marksans Pharma Ltd

Revenue
23.8B INR
Cost of Revenue
-10.6B INR
Gross Profit
13.2B INR
Operating Expenses
-8.9B INR
Operating Income
4.2B INR
Other Expenses
-767.8m INR
Net Income
3.5B INR

Free Cash Flow Analysis
Marksans Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MARKSANS Profitability Score
Profitability Due Diligence

Marksans Pharma Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive 3-Years Revenue Growth
Positive 3-Year Average ROE
61/100
Profitability
Score

Marksans Pharma Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

MARKSANS Solvency Score
Solvency Due Diligence

Marksans Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Marksans Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MARKSANS Price Targets Summary
Marksans Pharma Ltd

Wall Street analysts forecast MARKSANS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MARKSANS is 313.65 INR with a low forecast of 267.65 INR and a high forecast of 367.5 INR.

Lowest
Price Target
267.65 INR
9% Downside
Average
Price Target
313.65 INR
7% Upside
Highest
Price Target
367.5 INR
25% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MARKSANS?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MARKSANS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MARKSANS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one MARKSANS stock?

The intrinsic value of one MARKSANS stock under the Base Case scenario is 185.95 INR.

Is MARKSANS stock undervalued or overvalued?

Compared to the current market price of 293.7 INR, Marksans Pharma Ltd is Overvalued by 37%.

Back to Top